Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Weight-based chemotherapy dosing in obese patients with cancer: back to the future.

Literature DB >> 23181001

Weight-based chemotherapy dosing in obese patients with cancer: back to the future.

Gary H Lyman¹.

Abstract

Entities: Disease Species

Mesh：

Year: 2012 PMID： 23181001 PMCID： PMC3396832 DOI： 10.1200/JOP.2012.000606

Source DB: PubMed Journal: J Oncol Pract ISSN： 1554-7477 Impact factor: 3.840

× No keyword cloud information.

32 in total

Review 1. Systematic review of efficacy of dose-dense versus non-dose-dense chemotherapy in breast cancer, non-Hodgkin lymphoma, and non-small cell lung cancer.

Authors: Gary H Lyman; Richard L Barron; Jaime L Natoli; Ross M Miller
Journal: Crit Rev Oncol Hematol Date: 2011-06-01 Impact factor: 6.312

2. Analysis of the prognostic effects of inclusion in a clinical trial and of myelosuppression on survival after adjuvant chemotherapy for breast carcinoma.

Authors: C Mayers; T Panzarella; I F Tannock
Journal: Cancer Date: 2001-06-15 Impact factor: 6.860

3. Kinetics of mammary tumor cell growth and implications for therapy.

Authors: H E Skipper
Journal: Cancer Date: 1971-12 Impact factor: 6.860

Review 4. The importance of dose intensity in chemotherapy of metastatic breast cancer.

Authors: W Hryniuk; H Bush
Journal: J Clin Oncol Date: 1984-11 Impact factor: 44.544

Review 5. Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials.

Authors: Massimo Di Maio; Cesare Gridelli; Ciro Gallo; Frances Shepherd; Franco Vito Piantedosi; Silvio Cigolari; Luigi Manzione; Alfonso Illiano; Santi Barbera; Sergio Federico Robbiati; Luciano Frontini; Elena Piazza; Giovanni Pietro Ianniello; Enzo Veltri; Federico Castiglione; Francesco Rosetti; Vittorio Gebbia; Lesley Seymour; Paolo Chiodini; Francesco Perrone
Journal: Lancet Oncol Date: 2005-09 Impact factor: 41.316

6. Predictors of reduced dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapy.

Authors: Michelle Shayne; Jeffrey Crawford; David C Dale; Eva Culakova; Gary H Lyman
Journal: Breast Cancer Res Treat Date: 2006-05-17 Impact factor: 4.872

7. Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up.

Authors: G Bonadonna; P Valagussa; A Moliterni; M Zambetti; C Brambilla
Journal: N Engl J Med Date: 1995-04-06 Impact factor: 91.245

8. Incidence and predictors of low chemotherapy dose-intensity in aggressive non-Hodgkin's lymphoma: a nationwide study.

Authors: Gary H Lyman; David C Dale; Jonathan Friedberg; Jeffrey Crawford; Richard I Fisher
Journal: J Clin Oncol Date: 2004-09-20 Impact factor: 44.544

9. Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL.

Authors: Michael Pfreundschuh; Lorenz Trümper; Marita Kloess; Rudolf Schmits; Alfred C Feller; Christian Rübe; Christian Rudolph; Marcel Reiser; Dieter K Hossfeld; Hartmut Eimermacher; Dirk Hasenclever; Norbert Schmitz; Markus Loeffler
Journal: Blood Date: 2004-03-11 Impact factor: 22.113

10. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials.

Authors: R Peto; C Davies; J Godwin; R Gray; H C Pan; M Clarke; D Cutter; S Darby; P McGale; C Taylor; Y C Wang; J Bergh; A Di Leo; K Albain; S Swain; M Piccart; K Pritchard
Journal: Lancet Date: 2011-12-05 Impact factor: 79.321

10 in total

Review 1. Biophysics of cell membrane lipids in cancer drug resistance: Implications for drug transport and drug delivery with nanoparticles.

Authors: Chiranjeevi Peetla; Sivakumar Vijayaraghavalu; Vinod Labhasetwar
Journal: Adv Drug Deliv Rev Date: 2013-09-19 Impact factor: 15.470

2. Impact of body mass index on pathological complete response following neoadjuvant chemotherapy in operable breast cancer: a meta-analysis.

Authors: Haiyun Wang; Shijia Zhang; Douglas Yee; Saonli Basu; Heather Beckwith; David Potter; Anne Blaes
Journal: Breast Cancer Date: 2021-01-02 Impact factor: 4.239

Review 3. Chemotherapy dosing in overweight and obese patients with cancer.

Authors: Gary H Lyman; Alex Sparreboom
Journal: Nat Rev Clin Oncol Date: 2013-07-16 Impact factor: 66.675

Review 4. A Phenomic Perspective on Factors Influencing Breast Cancer Treatment: Integrating Aging and Lifestyle in Blood and Tissue Biomarker Profiling.

Authors: Ainhoa Arana Echarri; Mark Beresford; John P Campbell; Robert H Jones; Rachel Butler; Kenneth J Gollob; Patricia C Brum; Dylan Thompson; James E Turner
Journal: Front Immunol Date: 2021-02-01 Impact factor: 7.561

5. Dosing of chemotherapy in obese and cachectic patients: results of a national survey.

Authors: Helena Anglada-Martínez; Gisela Riu-Viladoms; Fernando do Pazo-Oubiña; Gloria Molas-Ferrer; Irene Mangues-Bafalluy; Carles Codina-Jané; Natàlia Creus-Baró
Journal: Int J Clin Pharm Date: 2014-04-27

6. Impact of race, ethnicity, and BMI on achievement of pathologic complete response following neoadjuvant chemotherapy for breast cancer: a pooled analysis of four prospective Alliance clinical trials (A151426).

Authors: Erica T Warner; Karla V Ballman; Carrie Strand; Judy C Boughey; Aman U Buzdar; Lisa A Carey; William M Sikov; Ann H Partridge
Journal: Breast Cancer Res Treat Date: 2016-07-22 Impact factor: 4.872